|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | (2013.01) |
| C12N 9/00 | (2006.01) | ||
| C12N 9/96 | (2006.01) | ||
| C07K 16/46 | (2013.01) | ||
| C07K 16/00 | (2013.01) | ||
| G01N 33/53 | (2006.01) | ||
| G01N 33/574 | (2006.01) | ||
| C07K2317/526 | (2013.01) | ||
| A61P 37/04 | (2006.01) | ||
| C07K2317/53 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K2317/60 | (2013.01) | ||
| C07K 16/46 | (2006.01) | ||
| C07K2317/94 | (2013.01) | ||
| C07K 16/08 | (2006.01) | ||
| C07K2319/30 | (2013.01) | ||
| A61P 29/00 | (2018.01) | ||
| C07K 16/12 | (2006.01) | ||
| A61P 37/00 | (2018.01) | ||
| C07K 16/00 | (2006.01) | ||
| A61P 37/02 | (2018.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61P 37/06 | (2018.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 37/00 | (2006.01) | ||
| A61P 37/02 | (2006.01) | ||
| A61P 37/06 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 3484514 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17803463.3 |
| Date of filing the European patent application | 2017-05-23 | |
| (97) | Date of publication of the European application | 2019-05-22 |
| (45) | Date of publication and mention of the grant of the patent | 2023-12-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/034084 |
| Date | 2017-05-23 |
| (87) | Number | WO 2017/205434 |
| Date | 2017-11-30 |
| (30) | Number | Date | Country code |
| 201662340322 P | 2016-05-23 | US | |
| 201762443451 P | 2017-01-06 | US |
| (72) |
BOSQUES, Carlos J. , US
LANSING, Jonathan C. , US
ORTIZ, Daniel , US
RUTITZKY, Laura , US
WASHBURN, Nathanial, J. , US
|
| (73) |
Momenta Pharmaceuticals, Inc. ,
1125 Trenton-Harbourton Road, Titusville, NJ 08560,
US
|
| (54) | COMPOSITIONS AND METHODS RELATED TO ENGINEERED FC CONSTRUCTS |
| COMPOSITIONS AND METHODS RELATED TO ENGINEERED FC CONSTRUCTS |